As of January 23, 2025, Orphazyme A/S (ORPHA.CO) has a market cap of $6.519 million USD. According to our data, Orphazyme A/S is ranked No.8974 in global market value.
Year | Market Cap | %Change |
---|---|---|
Oct 29, 2024 | $6.52 M |
-21.22%
|
Dec 29, 2023 | $7.74 M |
51.14%
|
Dec 30, 2022 | $5.12 M |
-94.87%
|
Dec 30, 2021 | $99.88 M |
-74.43%
|
Dec 30, 2020 | $0.39 B |
-7.32%
|
Dec 30, 2019 | $0.42 B |
67.01%
|
Dec 28, 2018 | $0.25 B |
-42.96%
|
Dec 29, 2017 | $0.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Amicus Therapeutics
FOLD
|
$2.85 B |
0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Takeda Pharmaceutical
TAK
|
$40.87 B |
0.001 M
|
Japan
|
CSL
CSL.AX
|
$82.07 B |
-0.055 B
|
Australia
|
Market Cap | = | ORPHA.CO Stock Price | * | ORPHA.CO Shares Outstanding |
= | $156.28 | * | 0.04 M | |
= | $6.52 M |